Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice

Br J Pharmacol. 2006 Nov;149(6):687-702. doi: 10.1038/sj.bjp.0706902. Epub 2006 Oct 3.

Abstract

Background and purpose: Glycogen synthase kinase-3 (GSK-3) is a ubiquitous serine-threonine protein kinase that participates in a multitude of cellular processes and has recently been implicated in the pathophysiology of a number of diseases. The aim of this study was to investigate the effects of GSK-3beta inhibition in a model of acute inflammation. Here, we have investigated the effects of TDZD-8, a potent and selective GSK-3beta inhibitor, in a mouse model of carrageenan-induced pleurisy.

Experimental approach: Injection of carrageenan into the pleural cavity of mice elicited an acute inflammatory response characterized by: accumulation of fluid containing a large number of neutrophils (PMNs) in the pleural cavity, infiltration of PMNs in lung tissues and subsequent lipid peroxidation, and increased production of nitrite/nitrate (NOx), prostaglandin E2 (PGE2), tumour necrosis factor-alpha, (TNF-alpha) and interleukin-1beta (IL-1beta). Furthermore, carrageenan induced an upregulation of the adhesion molecules ICAM-1 and P-selectin, iNOS, COX-2 as well as nitrotyrosine as determined by immunohistochemical analysis of lung tissues.

Key results: Administration of TDZD-8 (1, 3 or 10 mg kg(-1), i.p.), 30 min prior to injection of carrageenan, caused a dose-dependent reduction in all the parameters of inflammation measured.

Conclusions and implications: Thus, based on these findings we propose that inhibitors of the activity of GSK-3beta, such as TDZD-8, may be useful in the treatment of various inflammatory diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Carrageenan / toxicity*
  • Cyclooxygenase 2 / metabolism
  • Enzyme Inhibitors / pharmacology*
  • Glycogen Synthase Kinase 3 / antagonists & inhibitors*
  • Glycogen Synthase Kinase 3 beta
  • Immunohistochemistry
  • Lipid Peroxidation
  • Lung / cytology
  • Lung / drug effects*
  • Lung / enzymology
  • Male
  • Mice
  • NF-kappa B / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Peroxidase / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Thiadiazoles / pharmacology*
  • bcl-2-Associated X Protein / metabolism

Substances

  • 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
  • Enzyme Inhibitors
  • NF-kappa B
  • Proto-Oncogene Proteins c-bcl-2
  • Thiadiazoles
  • bcl-2-Associated X Protein
  • Carrageenan
  • Peroxidase
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, mouse
  • Glycogen Synthase Kinase 3